H. Onizawa

发表

FDG-PET/CT for Large-Vessel Vasculitis

T. Watabe, Xuena Li, U. Tateishi, 2019 .

The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection

Masao Tanaka, A. Morinobu, S. Akizuki, 2021, Arthritis Research & Therapy.

Oral dextran sulfate sodium administration induces peripheral spondyloarthritis features in SKG mice accompanied by intestinal bacterial translocation and systemic Th1 and Th17 cell activation

M. Hashimoto, Masao Tanaka, A. Morinobu, 2021, Arthritis Research & Therapy.

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

M. Hayakari, Masao Tanaka, S. Nakagawa, 2022, Pharmaceutical Research.

Detecting immunoglobulin G4-related intracranial arteriopathy with magnetic resonance vessel wall imaging: a preliminary experience in two cases

Kazumichi Yoshida, Y. Fushimi, Masahiro Tanji, 2022, BMC neurology.

Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice

M. Hashimoto, Masao Tanaka, A. Morinobu, 2022, Clinical Rheumatology.

ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis

T. Mimori, M. Hashimoto, Masao Tanaka, 2022, Frontiers in Immunology.

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis

H. Seno, Masao Tanaka, A. Morinobu, 2023, Arthritis Research & Therapy.

Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial

M. Hashimoto, Masao Tanaka, H. Arai, 2023, BMC Musculoskeletal Disorders.

Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort

M. Hashimoto, Masao Tanaka, W. Yamamoto, 2023, Immunological medicine.

CD8+ Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis

M. Hashimoto, Masao Tanaka, A. Morinobu, 2023, Journal of clinical medicine.

Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5.

Nan Yan, T. Mimori, T. Fujita, 2020, International immunology.

Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus.

M. Hashimoto, Masao Tanaka, A. Morinobu, 2023, Modern rheumatology.

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

Masao Tanaka, A. Morinobu, R. Hiwa, 2022, Lupus Science & Medicine.

How do symptoms of each joint contribute to global pain, disease activity and functional disability in rheumatoid arthritis?—A comprehensive association study using a large cohort

M. Hashimoto, Masao Tanaka, A. Morinobu, 2023, PloS one.

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort

T. Mimori, M. Hashimoto, Masao Tanaka, 2024, Arthritis research & therapy.

Predictive value of baseline concomitant glucocorticoid for abatacept-mediated long-term inhibition of radiographic progression: insights from the KURAMA cohort.

M. Hashimoto, Masao Tanaka, W. Yamamoto, 2023, Immunological medicine.

Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis.

K. Ohmura, M. Hashimoto, Masao Tanaka, 2022, Rheumatology.

Avacopan's potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis.

Tomoki Taniguchi, A. Morinobu, S. Akizuki, 2024, Modern rheumatology case reports.

Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study

M. Hashimoto, W. Yamamoto, Y. Etani, 2024, Clinical and experimental medicine.

Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study

M. Hashimoto, W. Yamamoto, K. Ebina, 2024, International journal of rheumatic diseases.

Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis

A. Morinobu, K. Murata, K. Murakami, 2024, Scientific reports.

Effect of high disease activity on spinal sagittal malalignment in patients with rheumatoid arthritis.

A. Morinobu, Y. Kuroda, S. Fujibayashi, 2024, Journal of neurosurgery. Spine.

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort.

Masao Tanaka, S. Nakagawa, A. Morinobu, 2024, Modern rheumatology.